Boston Scientific Corporation

Last updated September 27, 2026

Organization details

Legal name
Boston Scientific Corporation
Ownership
Public
Status
Active
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Marlborough
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BSX
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000885725
EIN
04-2695240

Board of directors

Chief executives

Michael F. Mahoney · Chairman, President & CEO
Dates unknown

Director election results

Annual meeting of April 30, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

12 of this board's directors also sit on 22 other boards.

Network of Boston Scientific Corporation's board connections Baxter International Inc. Baxter International I... CVS Health Corporation CVS Health Corporation Haemonetics Corporation Haemonetics Corporatio... Takeda Pharmaceutical Company Limited Takeda Pharmaceutical... Azenta Inc. Azenta Inc. Baker Hughes Company Baker Hughes Company Blaize Holdings Inc. Blaize Holdings Inc. Carnival Corporation Ltd. Carnival Corporation L... Concentra Group Holdings Parent Inc. Concentra Group Holdin... ConocoPhillips ConocoPhillips Danaher Corporation Danaher Corporation EnerSys EnerSys GMR Solutions Inc. GMR Solutions Inc. Keysight Technologies Inc. Keysight Technologies... Liftoff Mobile Inc. Liftoff Mobile Inc. Otis Worldwide Corporation Otis Worldwide Corpora... Cathy R. Smith Cathy R. Smith Charles J. Dockendorff Charles J. Dockendor... Cheryl Pegus Cheryl Pegus Christophe Pierre Weber Christophe Pierre We... David C. Habiger David C. Habiger Edward J. Ludwig Edward J. Ludwig Ellen M. Zane Ellen M. Zane Jessica L. Mega Jessica L. Mega Michael F. Mahoney Michael F. Mahoney Nelda J. Connors Nelda J. Connors Boston Scientific Corporat...
Shared director Other board Same sector +6 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$10,040,050
10 purchases by 5 insiders
Sold, last 12 months
$29,271,929
11 sales by 4 insiders
Date Insider Transaction Shares Price Value
Sep 2, 2026 O'Connor Padraig Andrew Officer (EVP, Global Operations) Option exercise +1,171 — —
Sep 2, 2026 O'Connor Padraig Andrew Officer (EVP, Global Operations) Shares withheld for tax −567 $48.37 $27,426
Aug 25, 2026 Susan E. Morano Director Open-market purchase +2,040 $49.22 $100,408
Aug 11, 2026 Woodworth Emily Officer (SVP, Global Controller and CAO) Discretionary transaction +2,930 $51.19 $149,987
Aug 10, 2026 Monson Jonathan Officer (EVP and CFO) Discretionary transaction +9,908 $50.46 $499,958
Aug 5, 2026 David C. Habiger Director Open-market purchase +2,100 $47.59 $99,937
Aug 4, 2026 David C. Habiger Director Open-market purchase +140 $48.59 $6,802
Aug 3, 2026 Michael F. Mahoney Director, Officer (Chairman, President & CEO) Open-market purchase +186,240 $48.33 $9,001,408
Aug 3, 2026 David C. Habiger Director Open-market purchase +1,042 $48.07 $50,084
Aug 3, 2026 Michael F. Mahoney Director, Officer (Chairman, President & CEO) Discretionary transaction +22,119 $48.43 $1,071,223
Jul 31, 2026 Fitzgerald Joseph Michael Officer (EVP & Group Pres, Cardiology) Discretionary transaction +64,198 $46.73 $2,999,973
Jul 31, 2026 Edward J. Ludwig Director Open-market purchase +5,000 $45.48 $227,400
Jul 1, 2026 Monson Jonathan Officer (EVP and CFO) Option exercise +2,087 — —
Jul 1, 2026 Monson Jonathan Officer (EVP and CFO) Shares withheld for tax −1,010 $43.06 $43,491
May 28, 2026 Michael F. Mahoney Director, Officer (Chairman, President & CEO) Gift −386,755 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.